Learn more about our Global Affairs work.
WASHINGTON, D.C. – FDA Commissioner Dr. Stephen Hahn joined a special meeting of AdvaMed®’s Board of Directors today to discuss how the medical technology industry and FDA can continue their work…
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed® member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…
The objective of this study is to assess the potential impact of pricing regulation of medical devices in Brazil, China, Colombia and India.
WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on the emergence of the coronavirus:
Contact: Jon [email protected] WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from Ralph Ives, executive vice president, global strategy and analysis, following release of a…
A matrix of AdvaMed® regional priorities for Latin America (LatAm) by country.
The medical technology industry – led by AdvaMed® – is eager to continue discussions with India’s government toward effective solutions, to help the government achieve its stated health care goals…
This white paper seeks to investigate the impact of medical technology on Japan’s initiatives to promote healthy aging, increase workforce participation, and retain skilled labor.
Many AdvaMed® members have made substantial investments in China, including establishment of research and manufacturing facilities and other efforts that contribute to China’s growth.